Cancer BiologyLeukemiaPeer-reviewed
A STAT3 Degrader Demonstrates Pre-clinical Efficacy in Venetoclax resistant Acute Myeloid Leukemia
Samarpana Chakraborty, Claudia Morganti, Kimberly S. Zaldana…·Aditi Shastri
This paper shows that targeting STAT3 with a degrader can overcome Venetoclax resistance in AML by reducing MCL1 and improving mitochondrial function.
14 citationstop 1%